Advertisement
Loading...

Genmab A/S

GNMSFā€¢PNK
Healthcare
Biotechnology
$269.50
$4.23(1.59%)
U.S. Market is Open ā€¢ 15:45

Genmab A/S (GNMSF) Stock Overview

Explore Genmab A/Sā€™s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap16.3B
P/E Ratio6.23
EPS (TTM)$13.16
ROE0.21%
Fundamental Analysis

AI Price Forecasts

1 Month$288.49
3 Months$321.25
1 Year Target$237.46

GNMSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Genmab A/S (GNMSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $237.46.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 6.23 and a market capitalization of 16.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-5.85%
3-Month Change
-6.73%
6-Month Change
-13.31%
Year-to-Date (YTD) Change
-15.52%
1-Year Change
40.50%
3-Year Change
-36.45%
5-Year Change
-29.03%
All-Time (Max) Change
1600.45%

Contact Information

https://www.genmab.com
45 70 20 27 28
Kalvebod Brygge 43, Copenhagen, NaN, 1560

Company Facts

2,638 Employees
IPO DateJan 5, 2010
CountryDK
Actively Trading

Frequently Asked Questions